Poster No:
1199
Submission Type:
Abstract Submission
Authors:
Congxiyu Wang1,2, Raihaan Patel1,2, Lucy Jobbins3, Clare Mackay1,2, Graham Reid1, Georgina Hobden4, Klaus P. Ebmeier1,5, Daniel Bulte6, Sana Suri1,2
Institutions:
1Department of Psychiatry, University of Oxford, Oxford, United Kingdom, 2Oxford Centre for Human Brain Activity (OHBA), Wellcome Centre for Integrative Neuroimaging (WIN), Oxford, United Kingdom, 3Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom, 4Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom, 5Wellcome Centre for Integrative Neuroimaging (WIN), Oxford, United Kingdom, 6Department of Engineering Science, University of Oxford, Oxford, United Kingdom
First Author:
Congxiyu Wang
Department of Psychiatry, University of Oxford|Oxford Centre for Human Brain Activity (OHBA), Wellcome Centre for Integrative Neuroimaging (WIN)
Oxford, United Kingdom|Oxford, United Kingdom
Co-Author(s):
Raihaan Patel
Department of Psychiatry, University of Oxford|Oxford Centre for Human Brain Activity (OHBA), Wellcome Centre for Integrative Neuroimaging (WIN)
Oxford, United Kingdom|Oxford, United Kingdom
Lucy Jobbins
Nuffield Department of Clinical Neuroscience, University of Oxford
Oxford, United Kingdom
Clare Mackay
Department of Psychiatry, University of Oxford|Oxford Centre for Human Brain Activity (OHBA), Wellcome Centre for Integrative Neuroimaging (WIN)
Oxford, United Kingdom|Oxford, United Kingdom
Graham Reid
Department of Psychiatry, University of Oxford
Oxford, United Kingdom
Georgina Hobden
Department of Experimental Psychology, University of Oxford
Oxford, United Kingdom
Klaus P. Ebmeier
Department of Psychiatry, University of Oxford|Wellcome Centre for Integrative Neuroimaging (WIN)
Oxford, United Kingdom|Oxford, United Kingdom
Sana Suri
Department of Psychiatry, University of Oxford|Oxford Centre for Human Brain Activity (OHBA), Wellcome Centre for Integrative Neuroimaging (WIN)
Oxford, United Kingdom|Oxford, United Kingdom
Introduction:
Cerebrovascular reactivity (CVR) refers to a vasodilation response of brain blood vessels to vasoactive stimuli. Impaired CVR is related to neurodegenerative diseases including dementia (Hayes et al., 2022). However, the mechanisms underlying the relationship between CVR and age-related cognitive impairments remain unclear. As brain atrophy is a biomarker for Alzheimer's Disease and aging (Pini et al., 2016), our study aims to explore the relationships between CVR, grey matter volume, white matter hyperintensities, white matter integrity, and cognitive function in aging. Additionally, we examined the moderating effect of dementia risk, computed using an established score, on these relationships, aiming to inform the potential interventions of the modifiable dementia risk factors in midlife.
Methods:
We recruited 163 participants (mean age=76.9±4.5) for the Heart and Brain Study (Suri et al., 2021). Participants underwent functional magnetic resonance imaging (MRI) to measure CVR under a 5% carbon dioxide respiratory challenge, structural MRI for grey matter volume (GMV), fluid attenuated inversion recovery for white matter hyperintensities (WMH), and diffusion tensor imaging for assessing white matter integrity (WMI). Cognition was evaluated using a battery of cognitive tests. Participants were stratified into high- or low-risk groups using the UK Biobank Dementia Risk Score (UKBDR) (Anatürk et al., 2023), which estimates midlife (mean age=52.5±4.4) dementia risk using retrospective records. Linear regression was performed to analyse associations between CVR (whole brain and lobe), and the MRI and cognitive outcomes while adjusting for age, sex, and total GMV. We also examined these associations separately for the high- and low-risk groups. Figure1 shows the details about the explanatory and outcome variables.

·Figure 1: Summary of Explanatory and Outcome Variables
Results:
In all participants, lower whole brain CVR significantly associated with smaller left nucleus accumbens (NAc) (p<0.01) and left thalamus volumes (p<0.05). Lobar analysis showed significant positive associations: parietal CVR with left hippocampus volume (p<0.05); temporal CVR with thalamus volume (p<0.05); frontal CVR with left thalamus and right NAc volumes (p<0.05); occipital CVR with right putamen (p=0.05). When stratifying by risk group, temporal CVR was positively related to left thalamus volume (p<0.05) exclusively in the high-risk group. In the low-risk group, whole brain CVR positively associated with temporoparietal junction volume (p<0.01). Left hippocampus volume positively associated with whole brain, frontal, parietal, and temporal CVR (p<0.05); frontal CVR positively related to right NAc volume (p<0.05). Regarding cognition, lower whole brain CVR was associated with worse fluency (p<0.01, primarily influenced by parietal CVR) and lower intelligence (p<0.05, primarily influenced by temporal CVR) only in the high-risk group. We found no associations between CVR with WMH or WMI in all participants or in either risk group.
Conclusions:
This study demonstrates how global and lobar CVR relates to brain structure and cognitive functions, and how these relationships are moderated by dementia risk, contributing to a more comprehensive understanding of cognitive aging. Impaired CVR associates with smaller NAc (reward processing) and smaller thalamus (sensory perception and memory). Significant positive associations between the hippocampus (cognitive processes), temporoparietal junction (social cognition and theory of mind), and CVR were only shown in the low dementia risk group. Conversely, positive associations between fluency and intelligence were evident only in the high dementia risk group. There could potentially be a cerebrovascular-brain structure reserve for individuals with high midlife dementia risk. However, they may exhibit diminished CVR and cognitive function in later life. Future research could explore mediating relationships among midlife dementia risk, vascular health, brain structure, and cognition.
Disorders of the Nervous System:
Neurodegenerative/ Late Life (eg. Parkinson’s, Alzheimer’s)
Lifespan Development:
Aging 1
Neuroanatomy, Physiology, Metabolism and Neurotransmission:
Anatomy and Functional Systems
Subcortical Structures
Physiology, Metabolism and Neurotransmission :
Cerebral Metabolism and Hemodynamics 2
Keywords:
Aging
Cognition
MRI
STRUCTURAL MRI
Sub-Cortical
Other - Cerebrovascular reactivity
1|2Indicates the priority used for review
Provide references using author date format
Anatürk, M., Patel, R. (2023). Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts. BMJ Ment Health, 26(1).
Hayes, G. (2022). Vascular smooth muscle cell dysfunction in neurodegeneration. Frontiers in Neuroscience, 16, 1010164.
Pini, L. (2016). Brain atrophy in Alzheimer’s disease and aging. Ageing research reviews, 30, 25-48.
Suri, S. (2021). Study Protocol: The Heart and Brain Study. Frontiers in Physiology, 12, 364.